Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
AppLovin resumed with a Buy at Citi » 16:03
12/08/21
12/08
16:03
12/08/21
16:03
APP

AppLovin

$95.89 /

-0.615 (-0.64%)

Citi analyst Jason…

Citi analyst Jason Bazinet resumed coverage of AppLovin with a Buy rating and $112 price target. The analyst says he likes the shares given the company's "strong growth prospects relative to its peers." He believes the Street will "ultimately pivot" from a sum-of-the-parts valuation to a levered free cash flow multiple.

ShowHide Related Items >><<
APP AppLovin
$95.89 /

-0.615 (-0.64%)

APP AppLovin
$95.89 /

-0.615 (-0.64%)

11/18/21
Fly Intel: Top five analyst initiations
11/18/21 Arete
AppLovin initiated with a Sell at Arete
11/12/21 Stifel
AppLovin price target raised to $125 from $110 at Stifel
11/11/21 Truist
AppLovin price target raised to $110 from $100 at Truist
APP AppLovin
$95.89 /

-0.615 (-0.64%)

  • 03
    Dec
  • 15
    Apr
APP AppLovin
$95.89 /

-0.615 (-0.64%)

APP AppLovin
$95.89 /

-0.615 (-0.64%)

Monday
Options
Largest borrow rate increases among liquid names » 08:45
12/06/21
12/06
08:45
12/06/21
08:45
BYSI

BeyondSpring

$4.02 /

-0.41 (-9.26%)

, ATNF

180 Life Sciences

$3.26 /

-0.605 (-15.65%)

, DOLE

Dole

$12.82 /

-0.34 (-2.58%)

, ARVL

Arrival Group

$7.71 /

-0.85 (-9.93%)

, SDS

UltraShort S&P500 ProShares

$7.85 /

+0.13 (+1.68%)

, ATHX

Athersys

$1.03 /

-0.06 (-5.53%)

, APP

AppLovin

$93.51 /

+3.19 (+3.53%)

, NAK

Northern Dynasty

/

+

, LABD

Daily S&P Biotech Bear 3x Shares

$29.80 /

+3.51 (+13.35%)

Latest data shows the…

Latest data shows the largest indicative borrow rate increases among liquid option names include: BeyondSpring (BYSI) 27.89% +1.41, Direxion Daily China Bear 3X Shares (YANG) 30.44% +0.58, 180 Life Sciences (ATNF) 8.35% +0.38, Dole plc (DOLE) 1.62% +0.30, Arrival (ARVL) 2.04% +0.28, ProShares UltraShort S&P 500 (SDS) 2.26% +0.26, Athersys (ATHX) 3.18% +0.25, Applovin (APP) 0.80% +0.23, Northern Dynasty (NAK) 7.16% +0.23, and Direxion S&P Biotech Bear 3X (LABD) 15.02% +0.22.

ShowHide Related Items >><<
NAK Northern Dynasty
/

+

LABD Daily S&P Biotech Bear 3x Shares
$29.80 /

+3.51 (+13.35%)

DOLE Dole
$12.82 /

-0.34 (-2.58%)

BYSI BeyondSpring
$4.02 /

-0.41 (-9.26%)

ATNF 180 Life Sciences
$3.26 /

-0.605 (-15.65%)

ATHX Athersys
$1.03 /

-0.06 (-5.53%)

ARVL Arrival Group
$7.71 /

-0.85 (-9.93%)

APP AppLovin
$93.51 /

+3.19 (+3.53%)

BYSI BeyondSpring
$4.02 /

-0.41 (-9.26%)

12/02/21 Evercore ISI
BeyondSpring price target lowered to $25 from $95 at Evercore ISI
12/02/21 Jefferies
Jefferies cuts BeyondSpring to Hold, slashes target to $5 after plinabulin CRL
12/02/21 Jefferies
BeyondSpring downgraded to Hold from Buy at Jefferies
12/01/21 BofA
BeyondSpring downgraded to Underperform from Buy at BofA
ATNF 180 Life Sciences
$3.26 /

-0.605 (-15.65%)

09/15/21 Maxim
180 Life Sciences initiated with a Buy at Maxim
09/15/21 Maxim
180 Life Sciences initiated with a Buy at Maxim
DOLE Dole
$12.82 /

-0.34 (-2.58%)

08/24/21
Fly Intel: Top five analyst initiations
08/24/21 BofA
BofA starts Dole at Underperform, says stock 'not ripe enough'
08/24/21 Stephens
Dole initiated with an Overweight at Stephens
08/24/21 Stephens
Dole initiated with an Overweight at Stephens
ARVL Arrival Group
$7.71 /

-0.85 (-9.93%)

12/02/21 UBS
Arrival Group initiated with a Neutral at UBS
10/06/21
Fly Intel: Top five analyst initiations
10/06/21 Berenberg
Berenberg starts 'differentiated' Arrival with Buy, $17 price target
10/06/21 Berenberg
Arrival initiated with a Buy at Berenberg
SDS UltraShort S&P500 ProShares
$7.85 /

+0.13 (+1.68%)

ATHX Athersys
$1.03 /

-0.06 (-5.53%)

11/19/21 BofA
Athersys downgraded to Neutral from Buy at BofA (yesterday)
02/17/21 Dawson James
Athersys management transition, standstill are positives, says Dawson James
APP AppLovin
$93.51 /

+3.19 (+3.53%)

11/18/21
Fly Intel: Top five analyst initiations
11/18/21 Arete
AppLovin initiated with a Sell at Arete
11/12/21 Stifel
AppLovin price target raised to $125 from $110 at Stifel
11/11/21 Truist
AppLovin price target raised to $110 from $100 at Truist
NAK Northern Dynasty
/

+

02/11/21 H.C. Wainwright
Northern Dynasty price target raised to $1.20 from 80c at H.C. Wainwright
LABD Daily S&P Biotech Bear 3x Shares
$29.80 /

+3.51 (+13.35%)

DOLE Dole
$12.82 /

-0.34 (-2.58%)

BYSI BeyondSpring
$4.02 /

-0.41 (-9.26%)

ATHX Athersys
$1.03 /

-0.06 (-5.53%)

ARVL Arrival Group
$7.71 /

-0.85 (-9.93%)

APP AppLovin
$93.51 /

+3.19 (+3.53%)

  • 03
    Dec
  • 19
    Nov
  • 30
    Jul
  • 15
    Apr
DOLE Dole
$12.82 /

-0.34 (-2.58%)

DOLE Dole
$12.82 /

-0.34 (-2.58%)

BYSI BeyondSpring
$4.02 /

-0.41 (-9.26%)

ATHX Athersys
$1.03 /

-0.06 (-5.53%)

ARVL Arrival Group
$7.71 /

-0.85 (-9.93%)

APP AppLovin
$93.51 /

+3.19 (+3.53%)

SDS UltraShort S&P500 ProShares
$7.85 /

+0.13 (+1.68%)

NAK Northern Dynasty
/

+

LABD Daily S&P Biotech Bear 3x Shares
$29.80 /

+3.51 (+13.35%)

DOLE Dole
$12.82 /

-0.34 (-2.58%)

BYSI BeyondSpring
$4.02 /

-0.41 (-9.26%)

ATNF 180 Life Sciences
$3.26 /

-0.605 (-15.65%)

ARVL Arrival Group
$7.71 /

-0.85 (-9.93%)

Friday
Syndicate
AppLovin 6.5M share Spot Secondary priced at $83.00 » 08:33
12/03/21
12/03
08:33
12/03/21
08:33
APP

AppLovin

$90.37 /

+4.09 (+4.74%)

The deal range was…

The deal range was $83.00-$85.00. JPMorgan, BofA, Citi and Morgan Stanley acted as joint book running managers for the offering.

ShowHide Related Items >><<
APP AppLovin
$90.37 /

+4.09 (+4.74%)

APP AppLovin
$90.37 /

+4.09 (+4.74%)

11/18/21
Fly Intel: Top five analyst initiations
11/18/21 Arete
AppLovin initiated with a Sell at Arete
11/12/21 Stifel
AppLovin price target raised to $125 from $110 at Stifel
11/11/21 Truist
AppLovin price target raised to $110 from $100 at Truist
APP AppLovin
$90.37 /

+4.09 (+4.74%)

  • 03
    Dec
  • 15
    Apr
APP AppLovin
$90.37 /

+4.09 (+4.74%)

Over a week ago
Syndicate
AppLovin 6.5M share Spot Secondary; price range $83.00-$85.00 » 16:28
12/02/21
12/02
16:28
12/02/21
16:28
APP

AppLovin

$90.37 /

+4.09 (+4.74%)

JPMorgan, BofA, Citi and…

JPMorgan, BofA, Citi and Morgan Stanley are acting as joint book running managers for the offering.

ShowHide Related Items >><<
APP AppLovin
$90.37 /

+4.09 (+4.74%)

APP AppLovin
$90.37 /

+4.09 (+4.74%)

11/18/21
Fly Intel: Top five analyst initiations
11/18/21 Arete
AppLovin initiated with a Sell at Arete
11/12/21 Stifel
AppLovin price target raised to $125 from $110 at Stifel
11/11/21 Truist
AppLovin price target raised to $110 from $100 at Truist
APP AppLovin
$90.37 /

+4.09 (+4.74%)

  • 15
    Apr
APP AppLovin
$90.37 /

+4.09 (+4.74%)

Syndicate
AppLovin announces launch of 6.5M shares of Class A common stock » 16:15
12/02/21
12/02
16:15
12/02/21
16:15
APP

AppLovin

$90.37 /

+4.09 (+4.74%)

AppLovin Corporation…

AppLovin Corporation announced that certain of AppLovin's stockholders, including KKR Denali Holdings, intend to offer for sale in an underwritten secondary offering 6.5M shares of the company's Class A common stock. J.P. Morgan, BofA Securities, Citigroup and Morgan Stanley will act as lead book-running managers for the offering. Credit Suisse, UBS Investment Bank and Goldman Sachs will act as additional book-running managers for the offering. Oppenheimer & Co., Stifel, William Blair, LionTree, LUMA Securities, The Raine Group, Blaylock Van, Guzman & Company, Roberts & Ryan and R. Seelaus & Co. will act as co-managers for the offering.

ShowHide Related Items >><<
APP AppLovin
$90.37 /

+4.09 (+4.74%)

APP AppLovin
$90.37 /

+4.09 (+4.74%)

11/18/21
Fly Intel: Top five analyst initiations
11/18/21 Arete
AppLovin initiated with a Sell at Arete
11/12/21 Stifel
AppLovin price target raised to $125 from $110 at Stifel
11/11/21 Truist
AppLovin price target raised to $110 from $100 at Truist
APP AppLovin
$90.37 /

+4.09 (+4.74%)

  • 15
    Apr
APP AppLovin
$90.37 /

+4.09 (+4.74%)

Syndicate
AppLovin files to sell $100M of Class A common stock for holders » 06:13
11/26/21
11/26
06:13
11/26/21
06:13
APP

AppLovin

$94.39 /

+1.34 (+1.44%)

J.P. Morgan, BofA…

J.P. Morgan, BofA Securities, and Citigroup are managing the offering.

ShowHide Related Items >><<
APP AppLovin
$94.39 /

+1.34 (+1.44%)

APP AppLovin
$94.39 /

+1.34 (+1.44%)

11/18/21
Fly Intel: Top five analyst initiations
11/18/21 Arete
AppLovin initiated with a Sell at Arete
11/12/21 Stifel
AppLovin price target raised to $125 from $110 at Stifel
11/11/21 Truist
AppLovin price target raised to $110 from $100 at Truist
APP AppLovin
$94.39 /

+1.34 (+1.44%)

  • 15
    Apr
APP AppLovin
$94.39 /

+1.34 (+1.44%)

Initiation
Fly Intel: Top five analyst initiations » 09:51
11/18/21
11/18
09:51
11/18/21
09:51
APP

AppLovin

$101.30 /

-4.1 (-3.89%)

, CRWD

Crowdstrike

$273.93 /

+4.3 (+1.59%)

, FISV

Fiserv

$100.85 /

-0.09 (-0.09%)

, SEAT

Vivid Seats

$12.76 /

+0.21 (+1.67%)

, SMG

Scotts Miracle-Gro

$170.35 /

+1.47 (+0.87%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. AppLovin (APP) initiated with a Sell at Arete. 2. Crowdstrike (CRWD) initiated with a Buy at DA Davidson. 3. Fiserv (FISV) initiated with a Neutral at UBS. 4. Vivid Seats (SEAT) initiated with an Outperform at Raymond James. 5. Scotts Miracle-Gro (SMG) initiated with an Overweight at Barclays. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
SMG Scotts Miracle-Gro
$170.35 /

+1.47 (+0.87%)

SEAT Vivid Seats
$12.76 /

+0.21 (+1.67%)

FISV Fiserv
$100.85 /

-0.09 (-0.09%)

CRWD Crowdstrike
$273.93 /

+4.3 (+1.59%)

APP AppLovin
$101.30 /

-4.1 (-3.89%)

APP AppLovin
$101.30 /

-4.1 (-3.89%)

11/18/21 Arete
AppLovin initiated with a Sell at Arete
11/12/21 Stifel
AppLovin price target raised to $125 from $110 at Stifel
11/11/21 Truist
AppLovin price target raised to $110 from $100 at Truist
11/11/21 Oppenheimer
AppLovin price target raised to $120 from $95 at Oppenheimer
CRWD Crowdstrike
$273.93 /

+4.3 (+1.59%)

11/18/21 DA Davidson
Crowdstrike initiated with a Buy at DA Davidson
11/15/21
Fly Intel: Top five analyst initiations
11/15/21 Morgan Stanley
Morgan Stanley starts Crowdstrike at Underweight amid competitive pressure
11/15/21 Mizuho
Crowdstrike price target raised to $360 from $330 at Mizuho
FISV Fiserv
$100.85 /

-0.09 (-0.09%)

11/18/21 UBS
Fiserv initiated with a Neutral at UBS
11/17/21 UBS
Fiserv initiated with a Neutral at UBS
11/01/21 JPMorgan
Fiserv earnings selloff seems overdone, says JPMorgan
10/28/21 RBC Capital
Fiserv price target lowered to $130 from $144 at RBC Capital
SEAT Vivid Seats
$12.76 /

+0.21 (+1.67%)

11/18/21 Raymond James
Raymond James starts reopening beneficiary Vivid Seats with an Outperform
11/18/21 Raymond James
Vivid Seats initiated with an Outperform at Raymond James
11/16/21 William Blair
Vivid Seats initiated with an Outperform at William Blair
11/12/21 Citi
Vivid Seats initiated with a Neutral at Citi
SMG Scotts Miracle-Gro
$170.35 /

+1.47 (+0.87%)

11/18/21 Barclays
Scotts Miracle-Gro initiated with an Overweight at Barclays
09/28/21 Truist
Scotts Miracle-Gro price target lowered to $225 from $250 at Truist
09/15/21 Raymond James
Scotts Miracle-Gro price target lowered to $200 from $230 at Raymond James
07/27/21 Stifel
Scotts Miracle-Gro initiated with a Buy at Stifel
SMG Scotts Miracle-Gro
$170.35 /

+1.47 (+0.87%)

SEAT Vivid Seats
$12.76 /

+0.21 (+1.67%)

FISV Fiserv
$100.85 /

-0.09 (-0.09%)

CRWD Crowdstrike
$273.93 /

+4.3 (+1.59%)

APP AppLovin
$101.30 /

-4.1 (-3.89%)

  • 30
    Apr
  • 15
    Apr
  • 10
    Dec
SMG Scotts Miracle-Gro
$170.35 /

+1.47 (+0.87%)

FISV Fiserv
$100.85 /

-0.09 (-0.09%)

CRWD Crowdstrike
$273.93 /

+4.3 (+1.59%)

SMG Scotts Miracle-Gro
$170.35 /

+1.47 (+0.87%)

SEAT Vivid Seats
$12.76 /

+0.21 (+1.67%)

FISV Fiserv
$100.85 /

-0.09 (-0.09%)

CRWD Crowdstrike
$273.93 /

+4.3 (+1.59%)

APP AppLovin
$101.30 /

-4.1 (-3.89%)

FISV Fiserv
$100.85 /

-0.09 (-0.09%)

CRWD Crowdstrike
$273.93 /

+4.3 (+1.59%)

Initiation
AppLovin initiated with a Sell at Arete » 05:15
11/18/21
11/18
05:15
11/18/21
05:15
APP

AppLovin

$105.40 /

-3.53 (-3.24%)

Arete initiated coverage…

Arete initiated coverage of AppLovin with a Sell rating and $82 price target.

ShowHide Related Items >><<
APP AppLovin
$105.40 /

-3.53 (-3.24%)

APP AppLovin
$105.40 /

-3.53 (-3.24%)

11/12/21 Stifel
AppLovin price target raised to $125 from $110 at Stifel
11/11/21 Truist
AppLovin price target raised to $110 from $100 at Truist
11/11/21 Oppenheimer
AppLovin price target raised to $120 from $95 at Oppenheimer
11/11/21 Credit Suisse
AppLovin price target raised to $115 from $95 at Credit Suisse
APP AppLovin
$105.40 /

-3.53 (-3.24%)

  • 15
    Apr
APP AppLovin
$105.40 /

-3.53 (-3.24%)

Recommendations
AppLovin price target raised to $125 from $110 at Stifel » 07:59
11/12/21
11/12
07:59
11/12/21
07:59
APP

AppLovin

$115.41 /

+19.33 (+20.12%)

Stifel analyst David Pang…

Stifel analyst David Pang raised the firm's price target on AppLovin to $125 from $110 and keeps a Buy rating on the shares. While Q3 results were only "slightly better than expected," underlying trends for the software platform business continued to gain momentum, making intermediate term targets for the segment "very achievable," Pang tells investors. He has increased estimates following the report, which reaffirmed his positive outlook for the software business.

ShowHide Related Items >><<
APP AppLovin
$115.41 /

+19.33 (+20.12%)

APP AppLovin
$115.41 /

+19.33 (+20.12%)

11/11/21 Truist
AppLovin price target raised to $110 from $100 at Truist
11/11/21 Oppenheimer
AppLovin price target raised to $120 from $95 at Oppenheimer
11/11/21 Credit Suisse
AppLovin price target raised to $115 from $95 at Credit Suisse
11/11/21 UBS
AppLovin price target raised to $118 from $112 at UBS
APP AppLovin
$115.41 /

+19.33 (+20.12%)

  • 15
    Apr
APP AppLovin
$115.41 /

+19.33 (+20.12%)

Recommendations
AppLovin price target raised to $110 from $100 at Truist » 08:47
11/11/21
11/11
08:47
11/11/21
08:47
APP

AppLovin

$95.93 /

-7.7 (-7.43%)

Truist analyst Youssef…

Truist analyst Youssef Squali raised the firm's price target on AppLovin to $110 from $100 and keeps a Buy rating on the shares after its "better" Q3 results, with "strong momentum" also continuing into Q4. Squali adds that he is incrementally bullish on AppLovin's growth prospects into the second half from Adjust, the planned rollout of several "evergreen" titles, and the pending MoPub acquisition.

ShowHide Related Items >><<
APP AppLovin
$95.93 /

-7.7 (-7.43%)

APP AppLovin
$95.93 /

-7.7 (-7.43%)

11/11/21 Oppenheimer
AppLovin price target raised to $120 from $95 at Oppenheimer
11/11/21 Credit Suisse
AppLovin price target raised to $115 from $95 at Credit Suisse
11/11/21 UBS
AppLovin price target raised to $118 from $112 at UBS
10/26/21 BTIG
AppLovin margins to approach roughly 40%, says BTIG
APP AppLovin
$95.93 /

-7.7 (-7.43%)

  • 15
    Apr
APP AppLovin
$95.93 /

-7.7 (-7.43%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.